tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ardelyx price target raised to $12 from $11 at Raymond James

Raymond James raised the firm’s price target on Ardelyx (ARDX) to $12 from $11 and keeps an Outperform rating on the shares. The substantial consensus beat and return to quarter over quarter growth suggests unfavorable Q1 seasonality is likely to remain prominent in out years, but also de-risks Ibserla guidance as well as the peak sales target for Xphozah, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1